These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19054570)

  • 21. Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients.
    Srivastava S; Wang PW; Hill SJ; Childers ME; Keller KL; Ketter TA
    J Psychiatr Res; 2012 Jul; 46(7):920-6. PubMed ID: 22579071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features.
    Tohen M; Kanba S; McIntyre RS; Fujikoshi S; Katagiri H
    J Affect Disord; 2014 Aug; 164():57-62. PubMed ID: 24856554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    J Affect Disord; 2012 Feb; 136(3):476-84. PubMed ID: 22134043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
    Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
    BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
    Houston JP; Lipkovich IA; Ahl J; Rotelli MD; Baker RW; Bowden CL
    J Psychiatr Res; 2007 Oct; 41(7):616-21. PubMed ID: 16236320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
    Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
    Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
    Yatham LN; Fountoulakis KN; Rahman Z; Ammerman D; Fyans P; Marler SV; Baker RA; Carlson BX
    J Affect Disord; 2013 May; 147(1-3):365-72. PubMed ID: 23290791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
    Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
    J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
    Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
    Gonzalez-Pinto A; Vieta E; Reed C; Novick D; Barraco A; Aguado J; Haro JM
    J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute dysphoric mania: treatment response to olanzapine versus placebo.
    Baker RW; Tohen M; Fawcett J; Risser RC; Schuh LM; Brown E; Stauffer VL; Shao L; Tollefson GD
    J Clin Psychopharmacol; 2003 Apr; 23(2):132-7. PubMed ID: 12640214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
    Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
    Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
    Vieta E; Calabrese JR; Hennen J; Colom F; Martínez-Arán A; Sánchez-Moreno J; Yatham LN; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2004 Oct; 65(10):1420-8. PubMed ID: 15491248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
    Vieta E; Montgomery S; Sulaiman AH; Cordoba R; Huberlant B; Martinez L; Schreiner A
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.
    Fu DJ; Turkoz I; Simonson RB; Walling DP; Schooler NR; Lindenmayer JP; Canuso CM; Alphs L
    J Clin Psychiatry; 2015 Mar; 76(3):253-62. PubMed ID: 25562685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of comorbid anxiety on treatment response in bipolar depression.
    Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
    J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of olanzapine in the treatment of bipolar I disorder.
    Lieberman DZ; Goodwin FK
    Expert Rev Neurother; 2004 Sep; 4(5):759-67. PubMed ID: 15853503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.